The Canadian Task Force on Preventive Health Care recommends against screening for prostate cancer with the PSA test
The CTFPHC found that the potential small benefit from PSA screening is outweighed by the potential significant harms of the screening and associated follow-up treatment.
Men should understand that PSA screening may result in additional testing if the PSA level is raised.
To save one life we would need to diagnose an additional 27 men with prostate cancer
Results of screening 1,000 men with the PSA test
What are my risks if I don’t get screened?
Among men who are screened with the PSA test, the risk of dying from prostate cancer is 5 in 1,000
Among men who are not screened with the PSA test, the risk of dying from prostate cancer is 6 in 1,000
Complications of treatment for prostate cancer
For every 1,000 men who receive treatment for prostate cancer:
114–214 will have short-term complications such as infections, additional surgeries, and blood transfusions
127–442 will experience long-term erectile dysfunction
up to 178 will experience urinary incontinence
4–5 will die from complications of prostate cancer treatment
Note
Statistics for benefits and harms were calculated from the European Randomized Study of Screening for Prostate Cancer (ERSPC).